{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:15:12Z","timestamp":1788869712730,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007705","name":"Astellas Pharma Global Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.nuclcard.2024.102050","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:39:47Z","timestamp":1728016787000},"page":"102050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The prognostic utility of heart rate and blood pressure response to regadenoson stress"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-1057","authenticated-orcid":false,"given":"Andrea","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-2327","authenticated-orcid":false,"given":"Alex","family":"Yerkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1303-4392","authenticated-orcid":false,"given":"Ayesha","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-9344","authenticated-orcid":false,"given":"Rami","family":"Doukky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2024.102050_bib1","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s12350-020-02135-y","article-title":"The prognostic value of regadenoson SPECT myocardial perfusion imaging: the largest cohort to date","volume":"28","author":"Kattoor","year":"2021","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12350-020-02259-1","article-title":"The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: the largest cohort to date","volume":"29","author":"Kolkailah","year":"2022","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12350-012-9533-x","article-title":"Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. \"The ASSUAGE trial\"","volume":"19","author":"Doukky","year":"2012","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10554-012-0166-6","article-title":"Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease-the ASSUAGE-CKD trial","volume":"29","author":"Doukky","year":"2013","journal-title":"Int J Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2024.102050_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12350-012-9654-2","article-title":"The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation","volume":"20","author":"Doukky","year":"2013","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ahj.2011.05.014","article-title":"The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease","volume":"162","author":"Hage","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.nuclcard.2024.102050_bib7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.amjcard.2009.01.007","article-title":"Relation between heart rate response to adenosine and mortality in patients with end-stage renal disease","volume":"103","author":"Venkataraman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12350-015-0234-0","article-title":"Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease","volume":"23","author":"AlJaroudi","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s12350-017-1061-2","article-title":"The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation","volume":"26","author":"AlJaroudi","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib10","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s12350-016-0497-0","article-title":"Impact of integrating heart rate response with perfusion imaging on the prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease","volume":"24","author":"Gomez","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12410-017-9409-1","article-title":"Stress SPECT myocardial perfusion imaging in end-stage renal disease","volume":"10","author":"Golzar","year":"2017","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1016\/j.nuclcard.2024.102050_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12350-017-0960-6","article-title":"Regadenoson use in chronic kidney disease and end-stage renal disease: a focused review","volume":"25","author":"Vij","year":"2018","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib13","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s12350-017-0901-4","article-title":"Validation of a clinical pathway to assess asymptomatic renal transplant candidates using myocardial perfusion imaging","volume":"25","author":"Doukky","year":"2018","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12350-014-0064-5","article-title":"Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging","volume":"23","author":"Poulin","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib15","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s12350-018-1415-4","article-title":"Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging","volume":"27","author":"Doukky","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s12350-011-9429-1","article-title":"A\u00a0blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging","volume":"18","author":"Hage","year":"2011","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12350-015-0387-x","article-title":"ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers","volume":"23","author":"Henzlova","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12350-010-9336-x","article-title":"Soft tissue attenuation patterns in stress myocardial perfusion SPECT images: a comparison between supine and upright acquisition systems","volume":"18","author":"Chawla","year":"2011","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-219X-1-22","article-title":"Diagnostic evaluation of three cardiac software packages using a consecutive group of patients","volume":"1","author":"Johansson","year":"2011","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nuclcard.2024.102050_bib20","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s00259-010-1522-1","article-title":"Comparison of diagnostic performances of three different software packages in detecting coronary artery disease","volume":"37","author":"Guner","year":"2010","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2024.102050_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2024.102050_bib22","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.113.002744","article-title":"Impact of appropriate use on the prognostic value of single-photon emission computed tomography myocardial perfusion imaging","volume":"128","author":"Doukky","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2024.102050_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A\u00a0method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.nuclcard.2024.102050_bib24","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCIMAGING.110.954784","article-title":"Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients","volume":"4","author":"Gerson","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102050_bib26","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/diacare.26.6.1895","article-title":"The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis","volume":"26","author":"Maser","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nuclcard.2024.102050_bib27","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/01.CIR.93.8.1520","article-title":"Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study","volume":"93","author":"Lauer","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2024.102050_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104907","article-title":"Heart rate variability in the prediction of mortality: a systematic review and meta-analysis of healthy and patient populations","volume":"143","author":"Jarczok","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.nuclcard.2024.102050_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12350-015-0269-2","article-title":"Heart rate response to regadenoson: making the case for its value in clinical practice","volume":"23","author":"Andrikopoulou","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102050_bib30","doi-asserted-by":"crossref","first-page":"35a","DOI":"10.1016\/S0735-1097(85)80461-7","article-title":"Digitalis and the autonomic nervous system","volume":"5","author":"Watanabe","year":"1985","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124007414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124007414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T10:48:19Z","timestamp":1737629299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358124007414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"alternative-id":["S1071358124007414"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2024.102050","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic utility of heart rate and blood pressure response to regadenoson stress","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2024.102050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Nuclear Cardiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102050"}}